Nolwenn Juhel

1.5k total citations · 1 hit paper
9 papers, 1.1k citations indexed

About

Nolwenn Juhel is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Cognitive Neuroscience. According to data from OpenAlex, Nolwenn Juhel has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Cognitive Neuroscience. Recurrent topics in Nolwenn Juhel's work include Neurological disorders and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Parkinson's Disease and Spinal Disorders (3 papers). Nolwenn Juhel is often cited by papers focused on Neurological disorders and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Parkinson's Disease and Spinal Disorders (3 papers). Nolwenn Juhel collaborates with scholars based in France, United States and United Kingdom. Nolwenn Juhel's co-authors include Kevin Flaherty, Andrew G. Nicholson, Matthias Klüglich, Ganesh Raghu, Abhya Gupta, Roland M. du Bois, Paul W. Noble, Moisés Selman, Luca Richeldi and David M. Hansell and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Neurology.

In The Last Decade

Nolwenn Juhel

9 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

2011 811 citations Luca Richeldi, Ulrich Costabel et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nolwenn Juhel France	6	760	286	257	127	113	9	1.1k
Maria Gisele Matheus United States	11	208 0.3×	259 0.9×	166 0.6×	61 0.5×	145 1.3×	16	661
K. Brühl Germany	11	98 0.1×	250 0.9×	89 0.3×	79 0.6×	146 1.3×	22	532
Yoichi Mashimo Japan	12	201 0.3×	109 0.4×	331 1.3×	481 3.8×	57 0.5×	24	835
Anna Elsa Maria Allegri Italy	18	211 0.3×	108 0.4×	63 0.2×	63 0.5×	65 0.6×	43	830
J. Patrick van der Voorn Netherlands	18	231 0.3×	105 0.4×	46 0.2×	66 0.5×	101 0.9×	32	926
Guilhem Solé France	15	95 0.1×	119 0.4×	176 0.7×	107 0.8×	64 0.6×	62	731
Elie Naddaf United States	16	150 0.2×	72 0.3×	445 1.7×	152 1.2×	319 2.8×	64	983
P Fleury Netherlands	14	80 0.1×	202 0.7×	126 0.5×	67 0.5×	39 0.3×	44	698
N. C. Notermans Netherlands	12	122 0.2×	116 0.4×	506 2.0×	77 0.6×	22 0.2×	22	644
Satoshi Suzuki Japan	12	88 0.1×	107 0.4×	202 0.8×	35 0.3×	57 0.5×	29	549

Countries citing papers authored by Nolwenn Juhel

Since Specialization

Citations

This map shows the geographic impact of Nolwenn Juhel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nolwenn Juhel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nolwenn Juhel more than expected).

Fields of papers citing papers by Nolwenn Juhel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nolwenn Juhel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nolwenn Juhel. The network helps show where Nolwenn Juhel may publish in the future.

Co-authorship network of co-authors of Nolwenn Juhel

This figure shows the co-authorship network connecting the top 25 collaborators of Nolwenn Juhel. A scholar is included among the top collaborators of Nolwenn Juhel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nolwenn Juhel. Nolwenn Juhel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Wang, Ying, Shenggang Sun, Suiqiang Zhu, et al.. (2014). The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson’s disease: a randomized, double-blind, double-dummy, parallel-group study. Translational Neurodegeneration. 3(1). 11–11. 13 indexed citations

2.

Richeldi, Luca, Kevin M. Brown, Ulrich Costabel, et al.. (2011). The Oral Triple Kinase Inhibitor BIBF 1120 Reduces Decline In Lung Function In Patients With Idiopathic Pulmonary Fibrosis (IPF): Results From The Tomorrow Study. A5303–A5303. 2 indexed citations

3.

Richeldi, Luca, Ulrich Costabel, Moisés Selman, et al.. (2011). Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis. New England Journal of Medicine. 365(12). 1079–1087. 811 indexed citations breakdown →

4.

Schapira, Anthony H.V., Paolo Barone, Robert A. Hauser, et al.. (2011). Extended-release pramipexole in advanced Parkinson disease. Neurology. 77(8). 767–774. 82 indexed citations

5.

Poewe, Werner, Olivier Rascol, Paolo Barone, et al.. (2011). Extended-release pramipexole in early Parkinson disease. Neurology. 77(8). 759–766. 64 indexed citations

6.

Deleporte, Amélie, Herlinde Dumez, Ahmad Awada, et al.. (2011). Phase I trial of volasertib (BI 6727), a polo-like kinase 1 (Plk1) inhibitor, in combination with cisplatin or carboplatin in patients with advanced solid tumors.. Journal of Clinical Oncology. 29(15_suppl). 3031–3031. 4 indexed citations

7.

Hauser, Robert A., Anthony H.V. Schapira, Olivier Rascol, et al.. (2010). Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. Movement Disorders. 25(15). 2542–2549. 80 indexed citations

8.

Schapira, Anthony H.V., Paolo Barone, R. Hauser, et al.. (2009). P2.159 Efflcacy and safety of once-daily (qd) pramipexole extended-release for advanced Parkinson's disease. Parkinsonism & Related Disorders. 15. S133–S133. 1 indexed citations

9.

Hauser, Robert A., et al.. (2006). Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease. Movement Disorders. 22(3). 359–365. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact